AJP - Endocrinology and Metabolism, Vol 268, Issue 1 E92-E99, Copyright © 1995 by American Physiological Society

ARTICLES

Effect of acute glucagon removal on metabolic response to infection in conscious dog

O. P. McGuinness, D. B. Lacy and J. Anderson
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee 37232-0615.

This study examined the acute role of glucagon in sustaining the increased hepatic gluconeogenesis observed in the conscious infected dog. After a basal sampling period, arterial glucagon levels were selectively decreased for 180 min by a peripheral infusion of somatostatin and basal intraportal infusion of insulin (GGN deficient; n = 6). In a separate protocol (GGN replaced; n = 5) glucagon was also infused intraportally to maintain the glucagon level at that seen during sepsis. Tracer and arteriovenous difference techniques were used to assess hepatic glucose metabolism and gluconeogenesis. In the GGN-deficient group the arterial plasma glucagon level fell from 416 +/- 49 to 88 +/- 21 pg/ml, whereas in the GGN-replaced group it remained elevated throughout (321 +/- 48 to 248 +/- 22 pg/ml). When glucagon was reduced, endogenous glucose production decreased by 1.6 +/- 0.3 mg.kg-1.min-1, and an exogenous glucose infusion was required to maintain euglycemia. Glucose metabolism remained unaltered when glucagon was replaced. When glucagon was deleted, net hepatic gluconeogenic precursor uptake was not altered. In contrast, the efficiency of gluconeogenesis was decreased by 33% compared with the GGN-replaced group. Liver biopsies taken at the end of the experiment indicated that a diversion of gluconeogenic carbon to glycogen accounted for 50% of the fall in gluconeogenic efficiency. In summary, the basal hyperglucagonemia seen during an infection helps sustain glucose production both through its effects on hepatic glycogen metabolism and on gluconeogenic efficiency.

This article has been cited by other articles:

				O. P. McGuinness, J. Ejiofor, D. B. Lacy, and N. Schrom Hepatic glucose metabolism during intraduodenal glucose infusion: impact of infection Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E108 - E115. [Abstract] [Full Text] [PDF]

				O. P. McGuinness, C. Donmoyer, J. Ejiofor, S. McElligott, and D. B. Lacy Hepatic and muscle glucose metabolism during total parenteral nutrition: impact of infection Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E763 - E769. [Abstract] [Full Text] [PDF]

				O. P. McGuinness, J. Ejiofor, L. P. Audoly, and N. Schrom Regulation of glucose production by NEFA and gluconeogenic precursors during chronic glucagon infusion Am J Physiol Endocrinol Metab, September 1, 1998; 275(3): E432 - E439. [Abstract] [Full Text] [PDF]

				C. S. Deutschman, K. M. Andrejko, B. A. Haber, L. Bellin, E. Elenko, R. Harrison, and R. Taub Sepsis-induced depression of rat glucose-6-phosphatase gene expression and activity Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1709 - R1718. [Abstract] [Full Text] [PDF]